Cargando…
Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications
Hitting the evasive tumor cells proves challenging in targeted cancer therapies. A general and unconventional anticancer approach namely small molecule sequential dual-targeting theragnostic strategy (SMSDTTS) has recently been introduced with the aims to target and debulk the tumor mass, wipe out t...
Autores principales: | Li, Junjie, Oyen, Raymond, Verbruggen, Alfons, Ni, Yicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572405/ https://www.ncbi.nlm.nih.gov/pubmed/23412554 http://dx.doi.org/10.7150/jca.5635 |
Ejemplares similares
-
Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID Mice Carrying Bifocal Tumor Xenografts
por: Li, Junjie, et al.
Publicado: (2013) -
Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents
por: Shabatina, Tatyana I., et al.
Publicado: (2023) -
Necrosis targeted combinational theragnostic approach to treat cancer
por: Ji, Yun, et al.
Publicado: (2014) -
Photo-Functionalized Magnetic Nanoparticles as a Nanocarrier of Photodynamic Anticancer Agent for Biomedical Theragnostics
por: Nam, Ki Chang, et al.
Publicado: (2020) -
A senolysis-based theragnostic prodrug strategy towards chronic renal failure
por: Song, Yihe, et al.
Publicado: (2022)